Investing.com - Aadi Bioscience (NASDAQ: AADI) reported first quarter EPS of $-0.6800, $0.05 worse than the analyst estimate of $-0.6300. Revenue for the quarter came in at $5.4M versus the consensus ...
Aadi Bioscience's stock price closed at $5.8400. It is down -15.9700% in the last 3 months and down -57.9300% in the last 12 months. Aadi Bioscience saw 1 positive EPS revisions and 1 negative EPS ...
Aadi Bioscience's stock price closed at $4.8200. It is down -18.4400% in the last 3 months and down -64.0600% in the last 12 months. Aadi Bioscience saw 0 positive EPS revisions and 4 negative EPS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback